(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -31.22% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 59.56%.
Rockwell Medical's revenue in 2025 is $101,489,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,377,173,016, with the lowest RMTI revenue forecast at $2,377,173,016, and the highest RMTI revenue forecast at $2,377,173,016.
In 2026, RMTI is forecast to generate $2,744,987,752 in revenue, with the lowest revenue forecast at $2,744,987,752 and the highest revenue forecast at $2,744,987,752.